REGN icon

Regeneron Pharmaceuticals

631 hedge funds and large institutions have $20.4B invested in Regeneron Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 249 increasing their positions, 215 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

11% less call options, than puts

Call options by funds: $497M | Put options by funds: $560M

12% less capital invested

Capital invested by funds: $23.1B → $20.4B (-$2.7B)

30% less first-time investments, than exits

New positions opened: 55 | Existing positions closed: 79

Holders
631
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$497M
Puts
$560M
Net Calls
Net Calls Change

Top Buyers

1 +$166M
2 +$86.4M
3 +$62.9M
4
BlackRock
BlackRock
New York
+$59.3M
5
Two Sigma Investments
Two Sigma Investments
New York
+$35.3M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.28B
2
$1.74B
3
$1.72B
4
$1.15B
5
$996M
6
$979M
7
$758M
8
$589M
9
$490M
10
$456M
11
$421M
12
$364M
13
$344M
14
$308M
15
$262M
16
$261M
17
$247M
18
$241M
19
$227M
20
$209M
21
$195M
22
$192M
23
$175M
24
$173M
25
$167M